Abstract

(1) Delays in initial treatment have been a frequently used metric for assessing disparities in medicine; however, there has been sparse literature on treatment delays in thyroid cancer. We therefore aimed to assess disparities by investigating the association between race/ethnicity, insurance type, and socioeconomic status and time to surgical treatment of thyroid cancer. (2) A retrospective chart review was conducted to collect demographic and clinical data from 443 surgical thyroid cancer patients at Mount Sinai Hospital in 2018–2019. We investigated the time between thyroid cancer diagnosis and surgery by race/ethnicity, insurance, and income groups. (3) Univariate analysis showed that race/ethnicity, insurance type, and SES alone were not statistically significant predictors of earlier time to treatment (p = 0.766, 0.339, 0.435, respectively). On multivariable linear regression, time between diagnosis and surgical treatment was not significantly different for racial minorities compared to non-Hispanic White patients, patients with Medicare/Medicaid compared to private insurance, and patients with lowest income quartile (<$54,585) compared to those with the highest (≥$116,560). (4) Present study showed no significant delays in treatment for different racial/ethnic, insurance, and income groups.

Original languageEnglish
Article number104284
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume45
Issue number4
DOIs
StatePublished - 1 Jul 2024

Keywords

  • Disparities
  • Surgery
  • Thyroid cancer
  • Treatment delays

Fingerprint

Dive into the research topics of 'Investigating potential disparities by exploring time to surgical thyroid cancer treatment'. Together they form a unique fingerprint.

Cite this